1-6 of 6
metabolic brain diseases
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pretransplant Risk Factors for Calcineurin Inhibitor-Induced Encephalopathy and Limbic Encephalitis Following Allogeneic Hematopoietic Cell Transplantation

Nao Tanizawa, MD, Hideo Koh, MD PhD, Hiroshi Okamura, MD PhD, Koh Shiro, MD PhD, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Asao Hirose, MD PhD, Mika Nakamae, MD PhD, Yasuhiro Nakashima, MD PhD, Takahiko Nakane, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4492.
https://doi.org/10.1182/blood-2019-124264
Published: 2019
Journal Articles

Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation: The Role of Calcineurin Inhibitors

Elisa Sala, MD, Stephanie von Harsdorf, MD, Verena Wais, MD, Thanh Mai Anne Nguyen, MD, Raphael Beck, MD, Hartmut Döhner, MD, Donald Bunjes, MD, Florian Kuchenbauer, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4601.
https://doi.org/10.1182/blood-2018-99-114977
Published: 2018
Journal Articles

The Related Factors and the Prognosis of Nervous System Complications on the Pediatric Patients with Hematopoietic Stem Cell Transplantation

Suxiang Liu, MD, Defei Zheng, MD, Peifang Xiao, MD, Yi Wang, MD, Zong Zhai, MD, Jun Lu, MD, Jie Li, MD, Shaoyan Hu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5718.
https://doi.org/10.1182/blood-2018-99-117803
Published: 2018
Journal Articles

Risk Factors and Impact of Neurological Complications after Allogeneic Hematopoietic Stem Cell Transplantation

Mark R. Dowling, MBBS, PhD, Shuli Li, Ashmeet Bhatia, MD, Areej El-Jawahri, MD, Bimal R. Dey, MD PhD, Steven L. McAfee, MD, Hanno Hock, MD PhD, Thomas R. Spitzer, MD, Yi-Bin Chen, MD, Karen K. Ballen, MD
Journal: Blood
Blood (2016) 128 (22): 5742.
https://doi.org/10.1182/blood.V128.22.5742.5742
Published: 2016
Journal Articles

Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) As Frontline Therapy for Older Patients (≥60 years) with Acute Lymphoblastic Leukemia (ALL)

Elias Jabbour, MD, Susan O'Brien, MD, Deborah A. Thomas, MD, Koji Sasaki, Guillermo Garcia-Manero, MD, Farhad Ravandi, MD, Gautam Borthakur, MD, Sergernne York, RN, Rebecca Garris, BSc, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2014) 124 (21): 794.
https://doi.org/10.1182/blood.V124.21.794.794
Published: 2014
Journal Articles

Early Neurologic Complications After Allogeneic Hematopoietic Stem Cell Transplantation in Children.

Kyung Nam Koh, Meerim Park, Keun Wook Bae, Hyoung Jin Kang, Ho Joon Im, Hyung Nam Moon, Jong Jin Seo
Journal: Blood
Blood (2009) 114 (22): 4314.
https://doi.org/10.1182/blood.V114.22.4314.4314
Published: 2009